002630.KS
ORIENT BIO Inc.
KSC · Healthcare · Biotechnology · KR
KRW 913.00
+8.69%Margins
Gross margin
17.5%
EBITDA margin
-19.2%
EBIT margin
-15.1%
Net margin
-27.8%
FCF margin
-0.8%
-12.1%
Return on equity
-10.2%
Return on assets
-6.2%
Return on invested capital
0.36x
Asset turnover
KRW 1.4B
Cash from operations
KRW 284
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025